Form D · Pharmaceuticals
RAPTOR PHARMACEUTICALS CORP.
Novato, CA · CIK 0001203944
Offering snapshot reported Sep 16, 2009 · SEC filing
- Reported sold
- $2.39M Offering amount: $2.39M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Aug 21, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2009 | Initial | $2,386,000 | No comparison | 4 | SEC filing |
| Jul 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 21, 2008 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $59.4K
- Form D file number
- 021-120712
Includes US and non-US sales.
Compensation provided to non-US placement agent on the basis of solicitation of non-US investors.
Source: Form D, filed Sep 16, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Raymond W. Anderson | Director |
| Erich Sager | Director |
| Christopher M. Starr | Director, Executive |
| Kim R. Tsuchimoto | Executive |
| Todd C. Zankel | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9 Commercial Blvd, Suite 200
Novato, CA, 94949
Novato, CA, 94949